Cybersecurity and privacy risk assessment of point-of-care systems in healthcare: A use case approach
Posted on September 7, 2021 By LabLynx Journal articles
Contents
Tools
Actions
General
- What links here
- Related changes
- Upload file
- Special pages
- Permanent link
- Page information
- Cite this page
- Get shortened URL
- Download QR code
- Wikidata item
Print/export
- Download as PDF
- Printable version
In other projects
Appearance
Identifiers | |
---|---|
3D model (JSmol)
|
|
| |
| |
Properties | |
C28H47I2N2O5P | |
Molar mass | 776.476 g·mol−1 |
Appearance | Solid |
Melting point | 124–126 °C (255–259 °F; 397–399 K) |
Soluble | |
Solubility | Soluble in alcohol, acetone and chloroform |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Extremely toxic |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
100 μg/kg (Rats, IV) 12 μg/kg (Rabbits, IV) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
EA-2613 is an extremely toxic organophosphate nerve agent. It's an extremely potent acetylcholinesterase inhibitor that is resistant to atropine and oxime treatment.[1]
See also
References
Animal toxins | |
---|---|
Bacterial | |
Cyanotoxins | |
Plant toxins | |
Mycotoxins | |
Pesticides | |
Nerve agents | |
Bicyclic phosphates | |
Cholinergic neurotoxins | |
Other |
Enzyme (modulators) |
| ||||||
---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||
Release (modulators) |
| ||||||
by LabLynx